- NIDA's Learn the Link Between HIV and Drug Abuse
- National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention (CDC)
- National Institute of Allergy and Infectious Diseases (NIAID)
- Office of National AIDS Policy
- NIH Office of AIDS Research (OAR)
- World Health Organization (WHO)
- Definition Tool for AIDS Grants (PDF, 180KB) - "Definition Tool" was developed to assist NIDA program officials in determining whether a grant application should be considered for funding with AIDS appropriated funds. The Definition Tool was first used in FY07; it was updated in FY13. The tool is designed to cover all NIDA-relevant AIDS research areas. It must be emphasized that this is a tool that begins the process of deciding which grants will be funded with AIDS dollars. Within NIDA, the Director of the AIDS Research Program (ARP) must approve all applications that will be funded with AIDS appropriated funds. The Office of AIDS Research (OAR) at NIH is the ultimate arbiter of whether a grant is appropriate for AIDS funding. An important consideration is that HIV/AIDS research should be integrated throughout the grant application.
- 10 Fatal Flaws in NIH Grant Submissions - PowerPoint presentation developed by Steffanie A. Strathdee, Ph.D. and Thomas L. Patterson, Ph.D.
- HIV Testing:
- National Institute on Drug Abuse Policy on HIV Education, Counseling, Testing, and Treatment for Research Subjects (NOT-DA-07-013)
- HIV Rapid Testing in Substance Abuse Treatment Programs: Resources to Support On-Site Rapid Testing
- Implementing Rapid HIV Testing With or Without Risk-Reduction Counseling in Drug Treatment Centers: Results of a Randomized Trial
- Effect of Risk-Reduction Counseling With Rapid HIV Testing on Risk of Acquiring Sexually Transmitted Infections: The AWARE Randomized Clinical Trial (Abstract also available on Pubmed)
- Research Ethics: